|
| 37666273 | Testosterone and the heart: friend or foe? | Climacteric | 2024 |
| 36366914 | Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies. | Climacteric | 2023 |
| 37591034 | Associations between low sex hormone concentrations and depression in older women: An observational study. | Maturitas | 2023 |
| 37902335 | The 2023 Practitioner's Toolkit for Managing Menopause. | Climacteric | 2023 |
| 37651151 | Dysmenorrhea, Workability, and Absenteeism in Australian Women. | J Womens Health (Larchmt) | 2023 |
| 37678251 | Menopause-Biology, consequences, supportive care, and therapeutic options. | Cell | 2023 |
| 37291814 | Misconceptions regarding dairy intake around thyroxine administration in pregnant and postpartum women. | Aust J Gen Pract | 2023 |
| 37101224 | The impact of endometriosis on work ability in young Australian women. | Aust N Z J Obstet Gynaecol | 2023 |
| 37330995 | Advancing menopause care in Australia: barriers and opportunities. | Med J Aust | 2023 |
| 36693423 | Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study. | Climacteric | 2023 |
| 36651193 | Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. | Hum Reprod Update | 2023 |
| 36585396 | Endogenous testosterone concentrations and muscle mass, strength and performance in women, a systematic review of observational studies. | Clin Endocrinol (Oxf) | 2023 |
| 36716780 | Sex hormones, SHBG and cognitive performance among older Australian women: an observational study. | Climacteric | 2023 |
| 36649577 | Endogenous dehydroepiandrosterone and depression in postmenopausal women: a systematic review of observational studies. | Menopause | 2023 |
| 36779420 | Menopause symptoms, sexual dysfunctions and pelvic floor disorders in refugee and asylum seeker women: a scoping review. | Climacteric | 2023 |
| 36807922 | The association between sex hormones and the change in brain-predicted age difference in older women. | Clin Endocrinol (Oxf) | 2023 |
| 36464322 | Testosterone for women: certainties and uncertainties. | Climacteric | 2023 |
| 36493634 | The association between testosterone and depression in postmenopausal women: A systematic review of observational studies. | Maturitas | 2023 |
| 34693971 | Approach to the Patient With New-Onset Secondary Amenorrhea: Is This Primary Ovarian Insufficiency? | J Clin Endocrinol Metab | 2022 |
| 35624141 | Treating menopause - MHT and beyond. | Nat Rev Endocrinol | 2022 |
| 36366886 | Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. | Lancet | 2022 |
| 35252940 | Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. | Lancet Healthy Longev | 2022 |
| 34981521 | Functional hypothalamic amenorrhoea: a diagnosis of exclusion. | Med J Aust | 2022 |
| 35106571 | Reply: A single cut-off value of anti-Mullerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women. | Hum Reprod | 2022 |
| 32705895 | Testosterone use in postmenopausal women. | Climacteric | 2021 |
| 33522319 | Androgens in premenopausal women and women with premature ovarian insufficiency. | Climacteric | 2021 |
| 33518180 | Use of Testosterone in Postmenopausal Women. | Endocrinol Metab Clin North Am | 2021 |
| 33906204 | A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. | Menopause | 2021 |
| 33792440 | International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. | Climacteric | 2021 |
| 33739311 | A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. | Menopause | 2021 |
| 33846715 | Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study. | Hum Reprod | 2021 |
| 33484146 | Letter to the Editor: "Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline". | J Clin Endocrinol Metab | 2021 |
| 33814355 | International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. | J Sex Med | 2021 |
| 33705583 | Differing performance of two assays for the measurement of anti-Mullerian hormone in premenopausal women: A cross-sectional study. | Clin Endocrinol (Oxf) | 2021 |
| 33797277 | International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. | J Womens Health (Larchmt) | 2021 |
| 34524701 | Testosterone and androstenedione are positively associated with anti-Müllerian hormone in premenopausal women. | Clin Endocrinol (Oxf) | 2021 |
| 34741176 | Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study. | Hum Reprod | 2021 |
| 34240683 | Health-care providers' views of menopause and its management: a qualitative study. | Climacteric | 2021 |
| 33973541 | A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. | Menopause | 2021 |
| 33459135 | BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020. | Post Reprod Health | 2021 |
| 33351205 | Longitudinal changes over three years in sex steroid hormone levels in women aged 70Â years and over. | Clin Endocrinol (Oxf) | 2021 |
| 33006500 | Prevalence of and Risk Factors for Depressive Symptoms and Antidepressant Use in Young Australian Women: A Cross-Sectional Study. | J Womens Health (Larchmt) | 2021 |
| 31180165 | Iron insufficiency among young Australian women: a population-based survey. | Intern Med J | 2020 |
| 32025718 | Distribution of Body Hair in Young Australian Women and Associations With Serum Androgen Concentrations. | J Clin Endocrinol Metab | 2020 |
| 31962012 | Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development. | Mol Genet Genomic Med | 2020 |
| 32052007 | Underlying Breast Cancer Risk and Menopausal Hormone Therapy. | J Clin Endocrinol Metab | 2020 |
| 32106994 | The prevalence of sexual dysfunctions and sexually related distress in young women: a cross-sectional survey. | Fertil Steril | 2020 |
| 32063470 | Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women. | J Sex Med | 2020 |
| 33252295 | Reflecting back and looking forward. | Climacteric | 2020 |
| 33110043 | The prevalence of hypoactive sexual desire disorder in Australian and Iranian women at midlife. | Menopause | 2020 |